arrow Log In to View Account     |      
HOME
Johns Hopkins Medicine
Hopkins Logo


Disclaimer: CME certification for these activities has expired. All information is pertinent to the timeframe in which it was released.


Advances In The Clinical Management Of Epilepsy In Senior Patients


GOAL
To provide primary care physicians with up-to-date information on the diagnosis and treatment selection in elderly patients with epilepsy.

TARGET AUDIENCE
This activity is designed for clinicians involved in the management of epilepsy in elderly patients in the primary care setting, including family medicine/practice physicians, general practice physicians, and internal medicine/internal medicine geriatric physicians. No prerequisites required.

LEARNING OBJECTIVES
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity. At the conclusion of this activity, participants should be able to:

  • Summarize the epidemiology and causes of epilepsy in the elderly.
  • List the different types of seizures that present in the elderly.
  • Identify the approach to diagnosis and treatment of new-onset seizures in the elderly.
  • Describe the benefits of treatment with the newer antiepileptic drugs in contrast to first-generation agents.

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.The estimated time to complete this educational activity: 1.5 hours.

Release date: March 15, 2006.
Expiration date: March 15, 2008.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

This program is supported by an educational grant from UCB Pharma.

Full Disclosure Policy Affecting CME Activities:
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:

PROGRAM DIRECTOR

Gregory Bergey, MD
Professor of Neurology
Director, The Johns Hopkins Epilepsy Center
Vice-Chair for Neurological Laboratories
The Johns Hopkins University School of Medicine
The Johns Hopkins Hospital
Baltimore, Maryland
Dr Bergey reports receiving grants/research support from Neuropace and NIH; serving as a consultant for Cyberonics, GlaxoSmithKline, Ortho-McNeil, Pfizer Inc, and UCB Pharma; and receiving honoraria from Abbott Laboratories, Eisai, GlaxoSmithKline, Novartis, Pfizer Inc, and UCB Pharma.

PARTICIPATING FACULTY

Angela K. Birnbaum, PhD
Associate Professor
Epilepsy Education and Research Program
University of Minnesota
Minneapolis, Minnesota
• Dr Birnbaum reports having no financial or advisory relationships with corporate organizations related to this activity.

Filissa M. Caserta, MSN, CRNP, CNRN
Certified Registered Nurse Practitioner  
Acute Care
Neuroscience Critical Care Unit
The Johns Hopkins University School of Medicine
The Johns Hopkins Hospital
Baltimore, Maryland
Ms Caserta reports having no financial or advisory relationships with corporate organizations related to this activity.

James A. Ferrendelli, MD
Professor and Chairman of Neurology
Department of Neurology
The University of Texas Medical School at Houston
Houston, Texas
Dr Ferrendelli reports having no financial or advisory relationships with corporate organizations related to this activity.

Jacqueline A. French, MD
Professor of Neurology
Director, Penn Epilepsy Center
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Dr French reports receiving research support from Abbott Laboratories, Carter-Wallace, Elan, GlaxoSmithKline, Johnson and Johnson/Ortho-McNeil, Medpointe, Novartis, Pfizer Inc, and UCB Pharma; serving on the speaker's bureau for Carter-Wallace, Elan, GlaxoSmithKline, Novartis, Ortho-McNeil, Pfizer Inc, and UCB Pharma; and serving as a consultant for Abbott Laboratories, Cyberonics, Eisai, Elan, GlaxoSmithKline, Medpointe, Novartis, Ortho-McNeil, Pfizer, Schwarz Pharma, and UCB Pharma.

Ilo Leppik, MD
Clinical Professor of Pharmacy and   Neurology
University of Minnesota
Director of Research for MINCEP Epilepsy Care
Minneapolis, Minnesota
Dr Leppik reports serving as a consultant for Abbott Laboratories and UCB Pharma; and receiving honoraria from Eisai and UCB Pharma.


Notice: The audience is advised that articles in this CME activity contain reference(s) to unlabeled or unapproved uses of drugs or devices.

Drs Bergey and French–initial monotherapy of gabapentin, lamotrigine, and levetiracetam.

All other faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.





Johns Hopkins Advanced Studies in Medicine (ISSN-1558-0334), is published by Galen Publishing, LLC, d/b/a ASiM, PO Box 340, Somerville, NJ 08876. (908) 253-9001. Copyright ©2012 by Galen Publishing. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. ASiM is a registered trademark of The Healthcare Media Group, LLC.